SARS-CoV-2

  • Novel Coronavirus (SARS-CoV-2) Multiplex Real-Time PCR Kit

    Novel Coronavirus (SARS-CoV-2) Qalabka Multiplex Real-Time PCR

    Cudurka cusub ee coronavirus waa fayraska RNA, oo ka kooban borotiinno iyo asiidh nucleic ah. Feyrasku wuxuu weeraraa jirka martida ah (bini'aadamka), wuxuu galaa unugyada iyadoo la adeegsanayo goobta isku xiraha daawada ACE2, wuxuuna ku celceliyaa unugyada martida, taasoo keenta in nidaamka difaaca bini'aadamka uu ka jawaabo shisheeyaha ku soo duulay soona saaro unugyada difaaca jirka ee gaarka ah. Sidaa darteed, asiidhyada nukliyeerka ah iyo antigens-ka, iyo unugyada difaaca jirka ee gaarka ah ee ka hortagga cudurka loo yaqaan 'coronavirus' ayaa aragti ahaan loo isticmaali karaa inay yihiin biomarkers gaar ah oo lagu ogaanayo coronavirus-ka cusub. Soo ogaanshaha nucleic acid, tiknoolajiyada RT-PCR ayaa ah tan ugu badan ee la isticmaalo.

    Novel Coronavirus (SARS-CoV-2) Multiplex Real-Time PCR Kit waxaa loogu talagalay in loogu isticmaalo in lagu gaaro ogaanshaha tayada SARS_CoV-2 virus RNA oo laga soosaaray nasopharyngeal swabs, oropharyngeal swabs, xaakada iyo BALF ee bukaanada kuxiran FDA / CE Nidaamka soo saarista IVD iyo jaangooyooyinka loogu talagalay PCR ee kor ku xusan.

    Qalabkan waxaa loogu talagalay inay adeegsadaan shaqaalaha shaybaarka tababbaran

  • SARS-CoV-2 IgM/IgG Antibody Rapid Test

    SARS-CoV-2 IgM / IgG Antibody Rapid Test

    Tallaabada 'StrongStep'®  Qalabka loo yaqaan 'SARS-CoV-2 IgM / IgG Antibody Rapid Test kit' waxaa loo isticmaalaa in lagu ogaado fitamiin ahaan ogaanshaha iyo aqoonsiga cudurka 'SARS-CoV-2 antibody coronavirus disease COVID-19 ee ku jira shay / plasma / shaybaarka dhiigga oo dhan (oo ay ku jiraan dhiigga xididka iyo dhiigga farta) bukaanka looga shakisan yahay ogaanshaha infekshinka waxaa loo isticmaali karaa in lagu ogaado shakhsiyaadka astaamaha ama asymptomatic ee qaba infekshinka ba'an iyo baaritaanka kelli ama macluumaadka kiliinikada.

    Imtixaanku wuxuu ku xadidan yahay Maraykanka in loo qaybiyo shaybaarada shahaado ka haysta CLIA si loo sameeyo baaritaan adag oo adag.

    Imtixaankan dib looma eegin FDA.

    Natiijooyinka taban kama horjoogsanayaan infekshinka daran ee SARS-CoV-2.

    Natiijooyinka ka soo baxa baaritaanka antibody-ka waa in aan loo isticmaalin in lagu baaro ama looga saaro cudurka daran ee SARS-CoV-2.

    Natiijooyinka togan waxaa laga yaabaa in ay ugu wacan tahay infekshin hore ama mid hadda jira oo aan ahayn SARS-CoV-2 noocyada coronavirus, sida coronavirus HKU1, NL63, OC43, ama 229E.

  • SARS-CoV-2 Antigen Rapid Test

    SARS-CoV-2 Antigen Degdega Imtixaanka

    Qalabka Nidaamka Biyosafety-ka ee loogu talagalay SARS-CoV-2 Antigen Test waxaa loo adeegsadaa ogaanshaha tayada ee coronavirus-ka cusub (SARS-CoV-2) antigen nucleocapsid (N) antigen-ka ee shaybaarka Cunnada / Nasopharyngeal swab ee vitro. Xirmada waa in kaliya loo adeegsadaa inay tahay tilmaame dheeri ah ama loo isticmaalo iyadoo lala kaashanayo ogaanshaha nucleic acid ee baaritaanka lagu tuhmayo kiisaska COVID-19. Looma isticmaali karo inay aasaas keli u tahay baaritaanka iyo ka-saarista bukaanka oof-wareenka ee uu ku dhaco cudurka cusub ee coronavirus, kumana haboona baaritaanka guud ee dadweynaha. Xirmooyinka ayaa aad ugu habboon in loo isticmaalo baaritaanka ballaaran ee dalal iyo gobollo uu si dhakhso leh ugu faafayo cudurka cusub ee coronavirus, iyo bixinta baaritaanka iyo xaqiijinta infekshanka COVID-19.

    MUHIIM: SOO SAARKAAN WAXA LOOGU TALAGALAY ISTICMAAL XIRFAD LEH KELIYA, UMA AQBAL IS-BARASHO AMA TIJAABINTA GURIGA!

  • Dual Biosafety System Device for SARS-CoV-2 Antigen Rapid Test

    Qalabka Nidaamka Biyosafety-ka ee loogu talagalay SARS-CoV-2 Antigen Rapid Test

    Qalabka Nidaamka Biyosafety-ka ee loogu talagalay SARS-CoV-2 Antigen Test waxaa loo adeegsadaa ogaanshaha tayada ee coronavirus-ka cusub (SARS-CoV-2) antigen nucleocapsid (N) antigen-ka ee shaybaarka Cunnada / Nasopharyngeal swab ee vitro. Xirmada waa in kaliya loo adeegsadaa inay tahay tilmaame dheeri ah ama loo isticmaalo iyadoo lala kaashanayo ogaanshaha nucleic acid ee baaritaanka lagu tuhmayo kiisaska COVID-19. Looma isticmaali karo inay aasaas keli u tahay baaritaanka iyo ka-saarista bukaanka oof-wareenka ee uu ku dhaco cudurka cusub ee coronavirus, kumana haboona baaritaanka guud ee dadweynaha. Xirmooyinka ayaa aad ugu habboon in loo isticmaalo baaritaanka ballaaran ee dalal iyo gobollo uu si dhakhso leh ugu faafayo cudurka cusub ee coronavirus, iyo bixinta baaritaanka iyo xaqiijinta infekshanka COVID-19. Tijaabadu waxay ku egtahay shaybaarro lagu sharciyeeyay qawaaniinta dawlada ama maamulada deegaanka.

  • System Device for SARS-CoV-2 & Influenza A/B Combo Antigen Rapid Test

    Qalabka Qalabka ee loogu talagalay SARS-CoV-2 & Hargabka A / B Combo Antigen Degdega ah

    Aaladda Nidaamka 'StrongStep®' ee loogu talagalay SARS-CoV-2 & Hargabka A / B Combo Antigen Rapid Test wuxuu u shaqeeyaa baaritaanka socodka wareega ee chromatographic. Waxaa jira saddex xarig oo aaladda ogaanaya SARS-CoV-2, nooca hargabka A iyo hargabka nooca B siday u kala horreeyaan, Latex conjugated antibody (Latex-Ab) oo u dhiganta SARS-CoV-2 / Ifilada A / Flu B ayaa qalalan dhamaadka silsilad kasta oo xuub nitrocellulose ah. SARS-CoV-2 / Flu A / Flu B unugyada jirka ayaa isku xidha aagga Imtixaanka (T) halka Biotin-BSA ay ku xidhan yihiin aagga xakamaynta (C) ee marin kasta Marka muunadda lagu daro, waxay u guurtaa kala-furfurnaanta fuuq-celinta ee fuuq-celinta conjugate latex. Hadday ku jirto muunad, SARS-CoV-2 / Ifilada A / Flu B antigens waxay ku xirnaan doontaa unugyada difaaca jirka ee ugu yar ee sameysmaya